CLINICAL_TRIALS
trial_result
· 2015-04-15
Clinical Trial Update: A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease [Phase 4]
Summary
Phase 4 study evaluating the safety and efficacy of Fabrazyme replacement therapy in patients with cardiac Fabry disease. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Genzyme, a Sanofi Company | Conditions: Fabry Disease | Phase 4 | Status: COMPLETED | Results posted: 2015-04-15